Satvik Pharmaceuticals Private Limited
About Satvik Pharmaceuticals Private Limited
Data last updated:
Satvik Pharmaceuticals Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the HR outsourcing and talent management segment of the business process outsourcing sector. It was incorporated on 13 May 2004.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2004PTC146274.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Rita Krishan Kumar Jethani and Krishan Kumar Jethani.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.57 Lakh, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹81,904 (net margin 31.9%) and EBITDA of ₹82,416 (EBITDA margin 32.1%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 14% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressOffice No.37 2nd Floor Horniman Circle Chambers, S.A. Brelvi Road Fort, Mumbai, Maharashtra, India – 400001
- IndustryBusiness Outsourcing, HR Outsourcing & Talent Management
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Satvik Pharmaceuticals Private Limited
The main business activity of Satvik Pharmaceuticals is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Satvik Pharmaceuticals Private Limited FY 2024 filings available
Satvik Pharmaceuticals Private Limited reported revenue of ₹2.57 Lakh (up 16% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Satvik Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 16% growth in the latest year. EBITDA fell 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Satvik Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹2.57 Lakh | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹82,416 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹81,904 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Satvik Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 32.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 31.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Satvik Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Satvik Pharmaceuticals Private Limited
Satvik Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Outsourcing industry (HR Outsourcing, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Salific Pharmaceuticals Private Limited | ₹2.59 Lakh (FY 2025) | •••• | •••• | -14.0% | •••• | Balrampur, Uttar Pradesh, India |
| Amd Trend Solution Private Limited | ₹2.58 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Mumbai, Maharashtra, India |
| Aditesh Pharmaceuticals Private Limited | ₹2.58 Lakh (FY 2021) | •••• | •••• | 20.0% | •••• | Lucknow, Uttar Pradesh, India |
| Crystila Pharmaceuticals Private Limited | ₹2.57 Lakh (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Teams Alliance Private Limited | ₹2.57 Lakh (FY 2025) | •••• | •••• | -59.0% | •••• | Patna, Bihar, India |
| Satvik Pharmaceuticals Private Limited this company | ₹2.57 Lakh (FY 2024) | •••• | •••• | 16.0% | •••• | Mumbai, Maharashtra, India |
| Acclimate Pharmaceuticals Private Limited | ₹2.55 Lakh (FY 2025) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Quantumnxt Ventures Private Limited | ₹2.55 Lakh (FY 2025) | •••• | •••• | -13.0% | •••• | Thane, Maharashtra, India |
| Rajahmundry Pharmaceuticals Private Limited | ₹2.55 Lakh (FY 2024) | •••• | •••• | -98.0% | •••• | Rajahmundry, Andhra Pradesh, India |
| Hunt N Hire Solutions Private Limited | ₹2.55 Lakh (FY 2025) | •••• | •••• | 68.0% | •••• | Vadodara, Gujarat, India |
| Vselek Private Limited | ₹2.54 Lakh (FY 2020) | •••• | •••• | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Satvik Pharmaceuticals by revenue in the Outsourcing industry (HR Outsourcing, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Satvik Pharmaceuticals Private Limited
Satvik Pharmaceuticals Private Limited is audited by Divya Nilesh Jain for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Divya Nilesh Jain | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Satvik Pharmaceuticals Private Limited
Satvik Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rita Krishan Kumar Jethani | Director | 30 Apr 2005 | 21 Years 5 Months | As last reported |
| Krishan Kumar Jethani Also directs: Satvik Pharmaceuticals LLP, Pun Energy and Envirotech Limited, K K Stock Management Private Limited and 1 more | Director | 30 Apr 2005 | 21 Years 5 Months | As last reported |
Ownership and Shareholding of Satvik Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Satvik Pharmaceuticals Private Limited
Satvik Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Satvik Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Satvik Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Satvik Pharmaceuticals Private Limited
Satvik Pharmaceuticals Private Limited has 2 board changes on record since 2005: 2 appointments. The latest: Krishan Kumar Jethani was appointed as Director on 30 Apr 2005.
Credit Ratings, Litigation & Regulatory Alerts for Satvik Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Satvik Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Satvik Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Satvik Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Satvik Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satvik Pharmaceuticals Private Limited
Satvik Pharmaceuticals has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Satvik Pharmaceuticals was a private limited company based in Mumbai, Maharashtra, India. The company worked in HR outsourcing and talent management, within the business outsourcing industry. It was incorporated on 13 May 2004 and is registered under CIN U24230MH2004PTC146274. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Satvik Pharmaceuticals is U24230MH2004PTC146274. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Satvik Pharmaceuticals had 2 directors:
- Rita Krishan Kumar Jethani - Director
- Krishan Kumar Jethani - Director
Satvik Pharmaceuticals was incorporated on 13 May 2004. It is registered with the Registrar of Companies, Mumbai.
The registered office of Satvik Pharmaceuticals is at Office No.37 2nd Floor Horniman Circle Chambers, S.A. Brelvi Road Fort, Mumbai, Maharashtra, India – 400001.
Satvik Pharmaceuticals reported revenue of ₹2.57 Lakh for FY 2024 (up 16% YoY).
Satvik Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Satvik Pharmaceuticals reported a net profit of ₹81,904 (net margin 31.9%) and EBITDA of ₹82,416 (EBITDA margin 32.1%) for FY 2024, as per its filed financial statements.
Satvik Pharmaceuticals operated in the business outsourcing industry, in the HR outsourcing and talent management segment.
The compounded annual growth rate (CAGR) of the revenue of Satvik Pharmaceuticals is 27% over three years and 14% over five years. In the latest year (FY 2024) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.